Home › Funds › HARBOURVEST PARTNERS LLC › GENB
HARBOURVEST PARTNERS LLC position in GENB
GENERATE BIOMEDICINES INC · Health Care
HARBOURVEST PARTNERS LLC reported holding 1,722,210 shares of GENB (GENERATE BIOMEDICINES INC) in its Q2 2026 13F filing — a position valued at US$29.1M, representing 17.09% of its reported portfolio and ranking #2 among its reported holdings. HARBOURVEST PARTNERS LLC has disclosed GENB holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How HARBOURVEST PARTNERS LLC's GENB position evolved
HARBOURVEST PARTNERS LLC first disclosed a stake in GENB in Q1 2026 at 1,722,210 shares (US$21.5M). The position peaked in Q2 2026 at 1,722,210 shares, worth US$29.1M. Across 2 filings, HARBOURVEST PARTNERS LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 1,722,210 shares valued at US$29.1M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 1.72M | $21.53M | New |
| Q2 2026 | 1.72M | $29.05M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GENB and 13F data
GENB (GENERATE BIOMEDICINES INC) is a Health Care company. 96 other funds we track also report a position in GENB — the largest reported positions include Flagship Pioneering, LLC (US$1.06B), BRAIDWELL LP (US$55.4M), ARCH Venture Management, LLC (US$32.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GENB
- Flagship Pioneering, LLC 62.67M sh · $1.06B · Q2 2026
- BRAIDWELL LP 3.28M sh · $55.40M · Q2 2026
- ARCH Venture Management, LLC 1.94M sh · $32.80M · Q2 2026
- BANQUE PICTET & CIE SA 1.77M sh · $26.63M · Q3 2026
- Harvard Management Company 1.11M sh · $18.74M · Q2 2026
- HARVARD MANAGEMENT CO INC 1.11M sh · $18.74M · Q2 2026
- NVIDIA CORP 833.33K sh · $14.06M · Q2 2026
- Davern Capital Partners, LP 824.68K sh · $13.91M · Q2 2026
More on HARBOURVEST PARTNERS LLC
FAQ
How long has HARBOURVEST PARTNERS LLC held GENB?
HARBOURVEST PARTNERS LLC has disclosed GENB holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is HARBOURVEST PARTNERS LLC's current position in GENB?
As of Q2 2026, HARBOURVEST PARTNERS LLC holds 1.72M shares of GENB (GENERATE BIOMEDICINES INC), valued at $29.05M, representing 17.09% of its reported portfolio and ranking #2.
Has HARBOURVEST PARTNERS LLC been buying or selling GENB?
In the latest 13F filing (Q2 2026), HARBOURVEST PARTNERS LLC held unchanged its position in GENB. The position peaked in Q2 2026 at 1.72M shares.
Which other funds hold GENB?
Other major institutional holders of GENB include Flagship Pioneering, LLC, BRAIDWELL LP, ARCH Venture Management, LLC, among 96 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.